Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2024

BUY
$117.53 - $155.99 $1,998 - $2,651
17 New
17 $2,000
Q1 2023

May 16, 2023

BUY
$117.53 - $155.99 $822 - $1,091
7 Added 70.0%
17 $2,000
Q2 2022

Aug 10, 2022

SELL
$62.69 - $88.44 $1,629 - $2,299
-26 Reduced 72.22%
10 $1,000
Q4 2021

Feb 15, 2022

BUY
$77.28 - $99.42 $77 - $99
1 Added 2.86%
36 $3,000
Q1 2021

May 13, 2021

BUY
$72.25 - $168.95 $1,011 - $2,365
14 Added 66.67%
35 $3,000
Q2 2020

Aug 13, 2020

SELL
$93.0 - $171.7 $372 - $686
-4 Reduced 16.0%
21 $3,000
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $2,059 - $3,290
25 New
25 $2,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $8.73B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.